Long-term efficacy and toxicity results of the FLUMIZ trial (fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in untreated follicular lymphoma)

Ann Oncol. 2012 Mar;23(3):805-807. doi: 10.1093/annonc/mdr633. Epub 2012 Jan 27.

¹ Department of Hematology and Medical Oncology "L. and A. Seràgnoli," S. Orsola-Malpighi Hospital, University of Bologna, Bologna. Electronic address: [email protected].
² Department of Hematology and Medical Oncology "L. and A. Seràgnoli," S. Orsola-Malpighi Hospital, University of Bologna, Bologna.
³ Department of Hematology, Azienda Ospedaliero-Universitaria Careggi, Firenze.
⁴ Department of Hematology, Azienda Ospedaliero-Universitaria Senese, Siena.
⁵ Department of Cellular Biotechnology and Hematology, University La Sapienza, Rome.
⁶ Department of Hematology, Azienda Ospedaliero-Universitaria San Martino, Genova.
⁷ Department of Hematology, S. Eugenio Hospital University "Tor Vergata," Rome.
⁸ Department of Hematology, S. Maria delle Croci Hospital, Ravenna.
⁹ Department of Hematology, La Cattolica University, Rome.
¹⁰ Division of Hematology, Cagliari Hospital, Cagliari.
¹¹ Department of Hematology, Federico II University, Naples, Italy.

No abstract available

Publication types